Comparative Assessment of Tedizolid Pharmacokinetics and Tissue Penetration between Diabetic Patients with Wound Infections and Healthy Volunteers via In Vivo Microdialysis

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2017-11-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1128/AAC.01880-17PMID 29109162PMCID PMC5740339
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Surveillance of tedizolid activity and resistance: In vitro susceptibility of Gram-positive pathogens collected over 5 years from the United States and Europe.

  2017cited by this paper
• Pharmacokinetics of Tedizolid in Obese and Nonobese Subjects

  2017cited by this paper
• The underappreciated in vitro activity of tedizolid against Bacteroides fragilis species, including strains resistant to metronidazole and carbapenems.

  2017cited by this paper
• Pharmacokinetics of Tedizolid in Morbidly Obese and Covariate-Matched Nonobese Adults

  2016cited by this paper
• Burden of Infected Diabetic Foot Ulcers on Hospital Admissions and Costs.

  2016cited by this paper
• Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial.

  2014cited by this paper
• Use of pharmacokinetic/pharmacodynamic systems analyses to inform dose selection of tedizolid phosphate.

  2014influential reference
• Tedizolid Population Pharmacokinetics, Exposure Response, and Target Attainment

  2014influential reference
• Tissue Pharmacokinetics of Cefazolin in Patients with Lower Limb Infections

  2013cited by this paper
• Pharmacokinetics of Tedizolid Following Oral Administration: Single and Multiple Dose, Effect of Food, and Comparison of Two Solid Forms of the Prodrug

  2013cited by this paper
• Skin and soft tissue concentrations of tedizolid (formerly torezolid), a novel oxazolidinone, following a single oral dose in healthy volunteers.

  2012cited by this paper
• Effect of Diabetes Mellitus on Pharmacokinetic and Pharmacodynamic Properties of Drugs

  2012cited by this paper
• Determination of Tissue Penetration and Pharmacokinetics of Linezolid in Patients with Diabetic Foot Infections Using In Vivo Microdialysis

  2011cited by this paper
• Tissue Penetration and Pharmacokinetics of Tigecycline in Diabetic Patients with Chronic Wound Infections Described by Using In Vivo Microdialysis

  2010cited by this paper
• Comprehensive foot examination and risk assessment. A report of the Task Force of the Foot Care Interest Group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists.

  2008cited by this paper
• Comprehensive Foot Examination and Risk Assessment

  2008cited by this paper
• Pharmacokinetic and pharmacodynamic aspects of antibiotic use in high-risk populations.

  2007cited by this paper
• Prevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers.

  2006influential reference
• Microdialysis

  2005cited by this paper
• Diagnosing and treating diabetic foot infections

  2004cited by this paper
• Incidence, outcomes, and cost of foot ulcers in patients with diabetes.

  1999cited by this paper
• Absorption of ciprofloxacin in patients with diabetic gastroparesis

  1995cited by this paper

• Dynamic distribution of systemically administered antibiotics in orthopeadically relevant target tissues and settings

  2024cites this paper
• Penetration of Antibiotics into Subcutaneous and Intramuscular Interstitial Fluid: A Meta-Analysis of Microdialysis Studies in Adults

  2024cites this paper
• Microdialysis as a tool for antibiotic assessment in patients with diabetic foot: a review

  2023cites this paper
• Exploiting recollection effects for memory-based video object segmentation.

  2023cites this paper
• Clinical practice recommendations for infectious disease management of diabetic foot infection (DFI) - 2023 SPILF.

  2023cites this paper
• Synovial fluid and plasma concentrations of tedizolid in patients with osteoarthritis infected with Staphylococcus aureus effectively determined with fluorescence detection

  2023cites this paper
• Pharmacokinetics and Pharmacodynamics of Tedizolid

  2022cites this paper
• Omadacycline pharmacokinetics and soft-tissue penetration in diabetic patients with wound infections and healthy volunteers using in vivo microdialysis

  2022cites this paper
• Importance and Reality of TDM for Antibiotics Not Covered by Insurance in Japan

  2022cites this paper
• Effect of the human endotoxin challenge on tedizolid tissue penetration

  2022influential citation
• Pharmacokinetics and soft-tissue distribution of tebipenem pivoxil hydrobromide using microdialysis: a study in healthy subjects and patients with diabetic foot infections.

  2022cites this paper
• The Role of Novel Antibiotics in the Management of Diabetic Foot Infection

  2022cites this paper
• Determination of Tedizolid in Bacterial Growth Medium Mueller-Hinton Broth by High-Performance Liquid Chromatography and Its Application to an In Vitro Study in the Hollow-Fiber Infection Model

  2021cites this paper
• Antibiotics in Necrotizing Soft Tissue Infections

  2021cites this paper
• Development of a simple method for measuring tedizolid concentration in human serum using HPLC with a fluorescent detector

  2021cites this paper
• Hot Topics in Diabetic Foot Infections.

  2020cites this paper
• Determination of free clindamycin, flucloxacillin or tedizolid in plasma: Keep attention to physiological conditions when using ultrafiltration.

  2020influential citation
• Tedizolid (torezolid) for the treatment of complicated skin and skin structure infections

  2020cites this paper
• Tedizolid: a service evaluation in a large UK teaching hospital

  2020cites this paper
• CE_A_187499 31..40

  2019cites this paper
• Tedizolid phosphate for the treatment of acute bacterial skin and skin-structure infections: an evidence-based review of its place in therapy

  2019cites this paper
• Expression and Activity of CYP2C8 and 2C9 in Diabetes Mellitus and Nonalcoholic Fatty Liver Disease

  2018cites this paper
• An evaluation of tedizolid for the treatment of MRSA infections

  2018cites this paper
• Pharmacokinetics of Tedizolid in an Obese Patient after Bariatric Surgery

  2018cites this paper